Drug pricing

Swiss healthcare costs rise faster than patients can keep up

A patient at the Swiss Paraplegic Centre walking down the corridor

This content was published on Jun 25, 2026 As Switzerland’s mandatory health insurance turns 30, an affordability crisis is forcing the country to take some difficult decisions to secure its future.

Schwan identified protectionism by the United ‌States and China as the firm's biggest geopolitical worry.

Healthcare innovation

Roche chair compares US tariff policy to ‘blackmail’

This content was published on Jun 5, 2026 Roche chair slams US tariffs as “blackmail" and warns rising US-China protectionism is top geopolitical risk.

Sandoz on the offensive against Chinese antibiotics on sale

Drug pricing

Swiss drugmaker complains of Chinese antibiotics dumping

This content was published on May 28, 2026 Sandoz steps up criticism of imports of low-priced antibiotics from China.

Drug pricing

Truth or tale: can pharma companies set prices for new drugs as high as they want?

This content was published on May 6, 2026 Debates over drug pricing have prompted Swissinfo readers to ask whether pharma companies can set prices for new drugs as high as they want.

Drug pricing

The drug-pricing problem no one wants to talk about

This content was published on May 4, 2026 Tackling the misuse of patents by some big pharma companies could go a long way to bringing down drug prices.

Full transparency from the FOPH on Covid-19 vaccines

Drug pricing

Swiss court forces Covid vaccine procurement transparency

This content was published on Apr 16, 2026 Court forces Switzerland to release unredacted Covid vaccine contracts from the pandemic.

US towards imposition of 100% duties on certain drugs

Trade policy

US expected to impose 100% tariffs on certain drugs: report

This content was published on Apr 2, 2026 The United States is preparing to impose 100% tariffs on certain drugs of pharma companies that haven't reached an agreement with the White House, the Financial Times reports.

Top-selling drugs discounted to lower premiums

Drug pricing

Switzerland mulls discounts on top-selling drugs to cut health costs

This content was published on Feb 19, 2026 The Swiss government has opened a consultation on limiting the steady rise of healthcare costs by granting discounts on best-selling medicines in the country.

Trump in White House. Pharma leaders behind him.

Drug pricing

The art of the deal: what are Trump’s pharma announcements really worth?

This content was published on Feb 18, 2026 Big Pharma announced a series of groundbreaking agreements with the White House in 2025. But how much of it is just for show?

Novartis: new global biomedical research centre opens in San Diego

Pharma supply chains

Novartis begins construction of new research centre in San Diego, US

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Drug pricing

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Drug pricing

More

Swiss healthcare costs rise faster than patients can keep up

More

Roche chair compares US tariff policy to ‘blackmail’

More

Swiss drugmaker complains of Chinese antibiotics dumping

More

Truth or tale: can pharma companies set prices for new drugs as high as they want?

More

The drug-pricing problem no one wants to talk about

More

Swiss court forces Covid vaccine procurement transparency

More

US expected to impose 100% tariffs on certain drugs: report

More

Switzerland mulls discounts on top-selling drugs to cut health costs

More

The art of the deal: what are Trump’s pharma announcements really worth?

More

Novartis begins construction of new research centre in San Diego, US

Popular Stories

Most Discussed